Newsroom
Kyprolis Trumps Velcade in Multiple Myeloma Trial
Results released by Amgen, who bought the molecule from Onyx, show that Kyprolis yielded better results when used as second-line in relapsed patients.
Study Analyzes Truth of IDN Claims of High-Quality, Low-Cost Care
Despite large claims that integrated delivery networks (IDNs) delivery higher quality care more efficiently and cost-effectively, a study of the nation’s 15 largest IDNs provided scant evidence to back them up, according to a new report.
Web-Based Tool Designed to Improve Quality of Care in Thyroid Cancer
The Thyroid Cancer Clinical Registry is expected to improve quality of patient care as patient data would be readily available to all physicians involved in the patients care; however former Commission on Cancer chair Frederick L Greene, MD, wonders whether physicians would take the time to enter the clinical data into the system as required.
Delayed HCV Treatment in Coinfected Patients Can Prove Fatal
Modeling data discussed at a press conference at the 2015 Conference on Retroviruses and Opportunistic Infections showed that delaying HCV treatment, consequent to the high cost of the newer antiviral regimens, could prove fatal in patients coninfected with HIV.
Despite Increased Health Data Breaches, Fines Remain Rare
In a string of meetings and press releases, the federal government's health watchdogs have delivered a stern message: They are cracking down on insurers, hospitals, and doctors offices that don't adequately protect the security and privacy of medical records.
Study on Chronic Fatigue May Help With Diagnoses
The immune systems of people with chronic fatigue syndrome differ from those of healthy people, and patients with recent diagnoses can be distinguished from those who have had the condition for longer, according to researchers.
List of Special Enrollment Events Continues to Expand
The list of situations that trigger a special, 60-day enrollment period will get longer in April, when a new rule issued by HHS takes effect.
Most Health-Related Websites Share Personal Info With Third-Parties
Third parties receive personal health information from more than 90% of visits to health-related websites, according to research to be published in the March 2015 issue of Communication of the ACM.
Urine Test for Bladder Cancer Could Aid Early Detection
A simple urine test could help to guide clinicians in the treatment of bladder cancer patients, researchers believe. Being able to reliably identify those patients with the most aggressive cancers early via urine tests, and expediting aggressive therapeutic strategies, may significantly improve outcomes, they say.
Providers Willing to Manage Chronic Care via Telehealth
A recent survey indicates healthcare providers are eager to adopt a chronic care management platform that would qualify them for newly available Medicare reimbursements.
Physicians Optimistic About ICD-10, But Not Prepared
Although physician practices are generally optimistic about being prepared for the October 1, 2015, transition date for ICD-10, only 21% admitted they are currently on track with preparations.
Managed Care Minute: February 28, 2015
A one-minute look at managed care news during the week of February 23, 2015, including another step by CMS toward a quality-based payment system and more predictions on the outcomes of King v. Burwell.
Increased Health Coverage Will Not Overly Burden US Healthcare Delivery System
Despite concerns that increasing healthcare coverage for Americans through the Affordable Care Act would lead to substantial strain on the US healthcare delivery system, The Commonwealth Fund found that increases will only modestly increase the demand for healthcare services.
Opdivo Gets Priority Review for NSCLC
BMS announced in a press release today that Opdivo (nivolumab), approved for advanced melanoma, has received priority review from the FDA for treating patients with advanced NSCLC.
Studies Highlight Limitations in Emergency Provider Understanding of End-of-Life Care Choices
Emergency care providers vary in their understanding of a type of medical order intended to communicate seriously ill patients' choices for life-sustaining treatments, according to a pair of studies recently published.
AJMC Panel Sees Advantages in FDA Regulation of Molecular Diagnostic Tests for Cancer Care
The American Journal of Managed Care convened a discussion of 2 leading clinicians and 2 medical directors for leading payers, all of whom saw some merit in FDA’s plans to bring oversight to the diagnostic testing market. The strongest advocate for greater FDA oversight was Daniel F. Hayes, MD, clinical director of the Breast Oncology Program at the University of Michigan, who will be a future president of the American Society of Clinical Oncology.
Community Oncology Alliance Announces Launch of Accreditation Pilot for OMH
Ten oncology practices around the nation will initiate their accreditation process this year, which includes an on-site survey bu the Commission on Cancer.
For Stakeholders in Immuno-Oncology, Is the Third Time the Charm?
Evidence-Based Oncology, an indexed publication of The American Journal of Managed Care, devotes its current issue to immuno-oncology and the interests of many stakeholders. In a commentary that draws on 30 years of waiting on the promise of immuno-oncology, Bruce Feinberg, DO, outlines the key issues facing payers, oncologists, policymakers and patients themselves.
Survey Finds Americans Better Able to Repay Healthcare Bills
A report released by the CDC, based on a survey conducted by the National Center for Health Statistics, found a significant decline since 2011.
Proposed Medicare Advantage Cuts Will Disrupt Care for Beneficiaries
Proposed payment cuts to Medicare Advantage (MA) could cause many beneficiaries to lose access to MA plans and cause great disruption to the market, according to a new report by Oliver Wyman for America’s Health Insurance Plans.
NICE Guidelines for Bladder Cancer Can Minimize Care Variance
NICE’s first guideline on bladder cancer aims to improve the diagnosis and management of the seventh most common cancer in the UK.
Electronic Alerts Do Not Necessarily Improve Care for Kidney Patients
The use of electronic alerts by hospitals treating patients with acute kidney injury may increase interventions without improving care, a study by Yale researchers found.
California Makes Strides in Mental Health, Slams Kaiser for Failures
While California has made great strides to improve mental health prevention and early intervention, the state's Department of Managed Health Care found causes for concern regarding Kaiser Permanente's behavioral health services.
First ICD-10 End-to-End Testing Yields Positive Results
With the International Classification of Diseases, Tenth Revision, definitely being implemented on October 1, 2015, CMS just completed the first week of end-to-end testing of the new coding.
Basket Trials Have FDA Support, But Will They Deliver?
Following the introduction of adaptive clinical trials, cancer researchers are now working on another revolutionary model, and they have the FDA's support in this effort. Named basket studies because they group different cancers together based on the driver mutation rather than the tumor of origin, these trials do not use the standard treatment as a control group, but look for a "Yes" or "No" response.